EHAB Enhabit, Inc. SERVICES-HOME HEALTH CARE SERVICES

Enhabit (EHAB) Stock: Buy, Sell, or Hold?

$13.80
+0.01 (+0.07%) ▲
5d: +0.22% 30d: +0.66% 90d: +22.99%
QUANTITATIVE VERDICT
WAIT
LOW Confidence (64%)
Quality Score
50/100
Position
FAIR
Forward P/E & Valuation
20.9x FAIR
vs 19.6x historical avg
Wall Street Target
$13.80
Consensus price target
Options IV & Volume
UNKNOWN Vol
UNKNOWN volume confirmation
Support / Resistance
$13.74 / $13.81
Trend: Strong Uptrend
💡Executive Thesis & Bottom Line
Forward Earnings Fair Value & Price Prediction →
â„šī¸ NEUTRAL: EHAB is fairly priced but lacks strong directional signals. At 2.1% expected growth, valuation appears fair. Wait for clearer setup or better entry on dips.

Get Alerted When EHAB Hits Your Target Price

Join 10,000+ traders who never miss a move

You're in! Check your email to confirm and set your target price.
100% Free No spam, ever Unsubscribe anytime

Interactive Price Chart (1 Month)

Loading chart...

Loading historical data...

Long-Term Wealth Forecast (2031)

Based on Analyst Consensus Growth & Historical Valuation

0% (Stagnation) 50% (Hyper Growth)
EST. PRICE IN 2031
$11.81
Based on -1.8% avg growth
INTRINSIC VALUE TODAY
$7.33
Trading above historical range

How this is calculated: We use a Growth Decay Model: starting with analyst consensus growth (adjusted above) and gradually slowing it down to a long-term terminal rate (4%) by Year 5. This provides a more realistic valuation than assuming constant hyper-growth. We then apply a 19.6x Exit PE.

In-depth Analysis How we analyze

Valuation Analysis: EHAB is currently trading at $13.80, which is considered fair based on recent price action. The stock's valuation (Forward PE: 20.9) is in line with its historical norms (19.6). At these levels, the market is pricing in 2.1% annual earnings growth. This growth rate appears achievable given the company's track record, suggesting the valuation is rational.

Technical Outlook: Technically, EHAB is in a strong uptrend. The price is currently testing key support at $13.74. A bounce from this level would confirm strength, while a break below could signal further downside.

Market Sentiment: The stock scores a mixed 40/100 on our bottoming-setup gauge, with only partial signs of a stabilized entry point. Current signals suggest waiting for a better entry point before initiating new positions.

Quick Decision Summary

Current Position FAIR
Company Quality Score 50/100 (HOLD)
Volume Confirmation UNKNOWN
Confidence Score 63.8%

Trading Range & Key Levels

Support Level $13.74
Resistance Level $13.81
Current Trend Strong Uptrend
Technical data as of May 14, 2026

Quantitative Signal Breakdown

  • NEUTRAL: Price in fair range
  • NEUTRAL: Mixed technical signals (40/100)
  • NEUTRAL: Near Wall St target ($13.80)
  • NEUTRAL: Market pricing in 2.1% annual earnings growth - fairly valued
  • WARNING: Composite score 50/100 in the bottom quintile — this cohort historically lags the market

Fundamental Context

Forward P/E (Next Year Est.) 20.87
Wall Street Target $13.80
Revenue Growth (YoY) 1.9%
Earnings Growth (YoY) 2.9%
Profit Margin -0.3%
Valuation Premium vs History +2.1% premium
PE vs Historical 20.9 vs 19.6 FAIR
Market-Implied Price Targets If current PE multiple persists
Implied Growth (YoY): +2.1% (market-implied from PE analysis)
1-Year Target $14.09 (+2%)
2-Year Target $14.39 (+4%)
3-Year Target $14.69 (+6%)
3-Yr Target (if PE normalizes) (PE: 21→20) PE COMPRESSION $13.79 (0%)
Earnings growth offset by PE compression
3-Year Scenarios Using analyst projected EPS growth
Bull: (PE: 22.0, Growth: -7.5%) $11.52 (+-17%)
Base: (SPY PE: 20.9, Growth: -7.5%) $10.91 (-21%)
Bear: (PE: 17.7, Growth: -7.5%) $9.27 (-33%)
Share EHAB Analysis

Share this live EHAB analysis (with rich preview card) to Reddit, StockTwits, X, or embed the chart on your blog.

bloggers & journalists: you are free to use our charts with attribution.
Last updated: November 11, 2026 9:42 AM ET
Data refreshes hourly during market hours. Next update: 10:42 AM
đŸ”Ĩ Top Stocks Breaking Out Now
Ticker Score Recommendation Change %
Technical Signals Check
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL

Unlock Insider Activity

See real-time buying/selling by company executives for EHAB.

Create Free Account

Already have an account? Log In

Top Rated Medical Care Facilities Stocks

Top-rated stocks in Medical Care Facilities by analyst ratings.

Stock Analyst Consensus Analyst Target Tradestie Score
THC
Tenet Healthcare Corporaâ€Ļ
STRONG BUY
23 analysts
$306 47 HOLD
CMPS
Compass Pathways Plc
STRONG BUY
16 analysts
$24 55 HOLD
HCA
HCA Healthcare, Inc.
BUY
26 analysts
$477 39 SELL
EHC
Encompass Health Corp
STRONG BUY
13 analysts
$156 34 SELL
CON
Concentra Group Holdingsâ€Ļ
STRONG BUY
11 analysts
$44 41 HOLD

Explore More Analysis & Live Quant Tools

Part A: Deep-Dive EHAB Research Pages
EHAB Technical Chart EHAB Price Prediction EHAB Intrinsic Value DCF EHAB Earnings Date EHAB Investment Advisor EHAB Fair Price Analyzer EHAB Competitors
Part B: Tradestie Flagship Market Scanners
Live Trades
From trading groups
Loading trades...
View All Live Trades See Trader Consensus & Signals